Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours

Cellular Oncology

Volumn 31, Issue 1, 2009, Pages 31-39

  Kuijper, Arno ^a   Snijders, Antoine M ^b   Berns, Els M J J ^c   Kuenen Boumeester, Vibeke ^c   Van Der Wall, Elsken ^a   Albertson, Donna G ^b,d   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Array CGH; Breast; Fibroadenoma; Phyllodes tumour

Indexed keywords

CADHERIN; DNA; PROTEIN P53;

ARTICLE; BREAST FIBROADENOMA; BREAST TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME 10; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 16; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 19; CHROMOSOME 1Q; CHROMOSOME 20; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 4P; CHROMOSOME 7P; CHROMOSOME 8Q; CLONE; COMPARATIVE GENOMIC HYBRIDIZATION; CYSTOSARCOMA PHYLLOIDES; DNA EXTRACTION; DNA ISOLATION; DNA MICROARRAY; GENE AMPLIFICATION; GENE LOSS; GENE SEQUENCE; GENOME ANALYSIS; GENOMIC INSTABILITY; HUMAN; HUMAN GENOME; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; TISSUE SECTION; TUMOR GENE; X CHROMOSOME;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYLLODES TUMOR;

EID: 58149379491     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0457     Document Type: Article

References (45)

1. L. Bernstein, D. Deapen and R.K. Koss, The descriptive epidemiology of malignant cystosarcoma phyllodes tumour of the breast, Cancer 71 (1993), 3020-3024.
2. C. Moffat, S. Pinder, A. Dixon, R. Blamey and I. Ellis, Phyllodes tumours of the breast: a clinicopathologic review of thirty-two cases, Histopathology 27 (1995), 205-218.
3. R.J. Barth Jr., Histologic features predict local recurrence after breast conserving therapy of phyllodes tumours, Breast Cancer Res. Treat. 57 (1999), 291-295.
4. A. Kuijper, R.A.I. de Vos, J.H. Lagendijk, E. van der Wall and P.J. van Diest, Progressive deregulation of the cell cycle with higher tumour grade in the stroma of breast phyllodes tumours, Am. J. Clin. Pathol. 123 (2005), 690-698.
5. V. Kuenen-Boumeester, S.C. Henzen-Logmans, M.M. Timmermans, I.L. van Staveren, A. van Geel, H.J. Peterse, J. Bonnema and E.M. Berns, Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast, J. Pathol. 189 (1999), 169-175.
6. C. Kersting, A. Kuijper, H. Schmidt, J. Packeisen, C. Leidtke, N. Tidow, C. Gustmann, B. Hinrichs, J. Tio, W. Boecker, P.J. van Diest, B. Brandt and H. Buerger, Amplifications of the epidermal growth factor receptor gene (EGFR) are common in phyllodes tumours of the breast and are associated with tumour progression, Lab. Invest. 86 (2006), 54-61.
7. A. Kuijper, P. van de Groep, E. van der Wall and P.J. van Diest, Role and prognostic relevance of HIF-1α and its downstream targets in fibroepithelial tumours of the breast, Breast Cancer Res. 7 (2005), R808-R818.
8. C.U. Dietrich, N. Pandis, G. Bardi, M.R. Teixeira, T. Soukhikh, C. Petersson, J.A. Andersen and S. Heim, Karyotypic changes in phyllodes tumours of the breast, Cancer Genet. Cytogenet. 76 (1994), 200-206.
9. C.U. Dietrich, N. Pandis, H. Rizou, C. Petersson, G. Bardi, H. Qvist, N. Apostolikas, P.J. Bohler, J.A. Andersen, I. Idvall, F. Mitelman and S. Heim, Cytogenetic findings in phyllodes tumours of the breast: karyotypic complexity differentiates between malignant and benign tumours, Hum. Pathol. 28 (1997), 1379-1382.
10. Y.J. Lu, S. Birdsall, P. Osin, B. Gusterson and J. Shipley, Phyllodes tumours of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence, Gen. Chromosom. Cancer 20 (1995), 275-281.
11. K.J. Jee, G. Gong, S. Hyun Ahn, J. Mi Park and S. Knuutila, Gain in 1q is a common abnormality in phyllodes tumours of the breast, Anal. Cell. Pathol. 25 (2003), 89-93.
12. D. Pinkel, R. Segraves, D. Sudar, S. Clark, I. Poole, D. Kowbel, C. Collins, W.L. Kuo, C. Chen, Y. Zhai, S.H. Dairkee, B.M. Ljung, J.W. Gray and D.G. Albertson, High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays, Nat. Genet. 20 (1998), 207-211.
13. S. Solinas-Toldo, S. Lampel, S. Stilgenbauer, J. Nickolenko, A. Benner, H. Dohner, T. Cremer and P. Lichter, Matrix-based comparative genomic hybridization: biochips to creen for genomic imbalances, Gen. Chromosom. Cancer 20 (1997), 399-407.
14. A.M. Snijders, N. Nowak, R. Segraves, S. Blackwood, N. Brown, J. Conroy, G. Hamilton, A.K. Hindle, B. Huey, K. Kimura, S. Law, K. Myambo, J. Palmer, B. Ylstra, J.P. Yue, J.W. Gray, A.N. Jain, D. Pinkel and D.G. Albertson, Assembly of microarrays for genome-wide measurement of DNA copy number, Nat. Genet. 29 (2001), 263-264.
15. D.G. Albertson, B. Ylstra, R. Segraves, C. Collins, S.H. Dairkee, D. Kowbel, W.L. Kuo, J.W. Gray and D. Pinkel, Quantative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene, Nat. Genet. 25 (2000), 144-146.
16. P.J. van Diest, J.P.A. Baak, P. Matze-Cok, E.C. Wisse-Brekelmans, C.M. van Galen, P.H. Kurver, S.M. Bellot, J. Fijnheer, L.H. van Gorp and W.S. Kwee, Reproducibility of mitosis counting in 2469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project, Hum. Pathol. 23 (1992), 603-607.
17. P.J. van Diest, For and against: No consent should be needed for using leftover body material for scientific purposes, BMJ 325 (2002), 648-651.
18. M.M. Weiss, M.A.J.A. Hermsen, G.A. Meijer, N.C.T. van Grieken, J.P. Baak, E.J. Kuipers and P.J. van Diest, Comparative genomic hybridization, Mol. Pathol. 52 (1999), 243-251.
19. G. Hamilton, N. Brown, V. Oseroff, B. Huey, R. Segraves, D. Sudar, J. Kumler, D. Albertson and D. Pinkel, A large field CCD system for quantitative imaging of microarrays, Nucleic Acids Res. 34 (2006), e58.
20. A.N. Jain, T.A. Tokuyasu, A.M. Snijders, R. Segraves, D.G. Albertson and D. Pinkel, Fully automatic quantification of microarray data, Genome Res. 12 (2002), 325-332.
21. A.M. Jones, R. Mitter, R. Springall, T. Graham, E. Winter, C. Gillett, A.M. Hanby, The Phyllodes Tumour Consortium, I.P.M. Tomlinson and E.J. Sawyer, A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence, J. Pathol. 214 (2008), 533-544.
22. T. Ried, K.E. Just, H. Holtgreve-Grez, S. du Manoir, M.R. Speicher, E. Schrock, C. Latham, H. Blegen, A. Zetterberg, T. Cremer and G. Auer, Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumours reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas, Cancer Res. 55 (1995), 5415-5423.
23. L.R. Cavalli, D.A. Cornelio, R.S. Lima, C.A. Urban, J.D. Rone, I.J. Cavalli and B.R. Haddad, Lack of DNA copy number alterations revealed with comparative genomic hybridization in fibroadenomas of the breast, Cancer Genet. Cytogenet. 153 (2004), 173-176.
24. D.G. Albertson, Profiling breast cancer by array CGH, Breast Cancer Res. Treat. 78 (2003), 289-298.
25. M.M. Weiss, E.J. Kuipers, C. Postma, A.M. Snijders, I. Siccama, D. Pinkel, J.Westerga, S.G. Meuwissen, D.G. Albertson and G.A. Meijer, Genomic profiling of gastric cancer predicts lymph node status and survival, Oncogene 22 (2003), 1872-1879.
26. M.M.Weiss, E.J. Kuipers, C. Postma, A.M. Snijders, M. Stolte, M. Vieth, D. Pinkel, S.G. Meuwissen, D.G. Albertson and G.A. Meijer, Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach, Mol. Pathol. 56 (2003), 293-298.
27. T. Ried, K. Heselmeyer-Haddad, H. Blegen, E. Schrock and G. Auer, Genomic changes defining the genesis, progression, and malignancy potential in solid human tumours: a phenotype/genotype correlation, Gen. Chromosom. Cancer 25 (1999), 195-204.
28. E. Hyman, P. Kauraniemi, S. Hautaniemi, M. Wolf, S. Mousses, E. Rozenblum, M. Ringner, G. Sauter, O. Monni, A. Elkahloun, O.P. Kallioniemi and A. Kallioniemi, Impact of DNA amplification on gene expression patterns in breast cancer, Cancer Res. 62 (2002), 6240-6245.
29. J.L. Phillips, S.W. Hayward, Y.Wang, J. Vasselli, C. Pavlovich, H. Padilla-Nash, J.R. Pezullo, M. Ghadimi, G.D. Grossfeld, A. Rivera, M. Linehan, G.R. Cunha and T. Ried, The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis, Cancer Res. 61 (2001), 8143-8149.
30. R. Redon, D. Muller, K. Caulee, K. Wanherdrick, J. Abecassis and S. du Manoir, A simple specific pattern of chromosomal aberrations at early stages of head and neck sqaumous carcinomas: PIK3CA but not p63 gene as a target of 3q26-qter gains, Cancer Res. 61 (2001), 4122-4129.
31. L. Shayesteh, Y. Lu, L. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, D. Powell, G.B. Mills and J.W. Gray, PIK3CA is implicated as an oncogene in ovarian cancer, Nat. Genet. 21 (1999), 64-65.
32. J.A. Veltman, J. Fridlyand, S. Pejavar, A.B. Olshen, J.E. Korkola, S. DeVries, P. Carroll, W.L. Kuo, D. Pinkel, D. Albertson, C. Cordon-Cardo, A.N. Jain and F.M. Waldman, Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumours, Cancer Res. 63 (2003), 2872-2880.
33. H. van Dekken, P.L. Paris, D.G. Albertson, J.C. Alers, A. Andaya, D. Kowbel, T.H. van der Kwast, D. Pinkel, F.H. Schroder, K.J. Vissers, M.F. Wildhagen and C. Collins, Evaluation of genetic patterns in different tumour areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis, Gen. Chromosom. Cancer 39 (2004), 249-256.
34. J.E. Etzel, S. Devries, K. Chew, C. Florendo, A. Molinaro, B.M. Ljung and F.M. Waldman, Loss of chromosome 16q in lobular carcinoma in situ, Hum. Pathol. 32 (2001), 292-296.
35. A.C. Han, A.P. Soler, K.A. Knudsen and H. Salazar, Distinct cadherin profiles in special variant carcinomas and other tumours of the breast, Hum. Pathol. 30 (1999), 1035-1039.
36. C. Yin, S.J. Korsmeyer and T. van Dyke, Bax suppresses tumorigenesis and stimulates apoptosis in vivo, Nature 385 (1997), 637-640.
37. Z. Gatalica, S. Finkelstein, E. Lucio, O. Tawfik, J. Palazzo, B. Hightower and E. Eyzaguirre, p53 protein expression and gene mutation in phyllodes tumors of the breast, Pathol. Res. Pract. 197 (2001), 183-187.
38. R.C. Bargou, C. Wagener, K. Bommert, M.Y. Mapara, P.T. Daniel, W. Arnold, M. Dietel, H. Guski, H. Feller, H.D. Royer and B. Dorken, Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumour growth in SCID mice, J. Clin. Invest. 97 (1996), 2651-2659.
39. S. Krajewski, C. Blomqvist, K.Franssila, M. Krajewska, V.M. Wasenius, E. Niskanen, S. Nordling and J.C. Reed, Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma, Cancer Res. 55 (1995), 4471-4478.
40. G. Asher, J. Lotem, B. Cohen, L. Sachs and Y. Shaul, Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1, Proc. Natl. Acad. Sci. USA 98 (2001), 1188-1193.
41. E.J. Sawyer, R. Poulsom, F.T. Hunt, R. Jeffery, G. Elia, I.O. Ellis, P. Ellis, I.P.M. Tomlinson and A.M. Hanby, Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit, J. Pathol. 200 (2003), 59-64.
42. G.N. Filippova, S. Fagerlie, E.M. Klenova, C. Myers, Y. Dehner, G. Goodwin, P.E. Neiman, S.J. Collins and V.V. Lobanenkov, An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes, Mol. Cell. Biol. 16 (1996), 2802-2813.
43. G.N. Filippova, A. Lindblom, L.J. Meincke, E.M. Klenova, P.E. Neiman, S.J. Collins, N.A. Doggett and V.V. Lobanenkov, A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers, Gen. Chromosom. Cancer 22 (1998), 26-36.
44. K. Agelopoulos, C. Kersting, E. Korshing, H. Schmidt, A. Kuijper, C. August, P. Wulfing, J. Tio, W. Boecker, P.J. van Diest, B. Brandt and H. Buerger, EGFR amplification specific gene expression in phyllodes tumours of the breast, Cell. Oncol. 29 (2007), 443-451.
45. A.S. Ishkanian, C.A. Malloff, S.K. Watson, R.J. DeLeeuw, B. Chi, B.P. Coe, A. Snijders, D.G. Albertson, D. Pinkel, M.A. Marra, V. Ling, C. MacAulay and W.L. Lam, A tiling resolution DNA microarray with complete coverage of the human genome, Nat. Genet. 36 (2004), 299-303.